Oliver Sander

1.8k total citations
73 papers, 1.0k citations indexed

About

Oliver Sander is a scholar working on Rheumatology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Oliver Sander has authored 73 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 34 papers in Rheumatology, 20 papers in Immunology and 12 papers in Pathology and Forensic Medicine. Recurrent topics in Oliver Sander's work include Systemic Lupus Erythematosus Research (16 papers), Rheumatoid Arthritis Research and Therapies (14 papers) and Systemic Sclerosis and Related Diseases (11 papers). Oliver Sander is often cited by papers focused on Systemic Lupus Erythematosus Research (16 papers), Rheumatoid Arthritis Research and Therapies (14 papers) and Systemic Sclerosis and Related Diseases (11 papers). Oliver Sander collaborates with scholars based in Germany, United States and Switzerland. Oliver Sander's co-authors include Matthias Schneider, R. Rau, Rebecca Fischer‐Betz, Gamal Chehab, G. Herborn, Jutta Richter, Hubertus Hautzel, Alexander Heinzel, Hans‐Wilhelm Müller and Ralph Brinks and has published in prestigious journals such as SHILAP Revista de lepidopterología, PEDIATRICS and Scientific Reports.

In The Last Decade

Oliver Sander

65 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Oliver Sander Germany 19 427 281 160 127 126 73 1.0k
Josef Zadražil Czechia 17 241 0.6× 203 0.7× 104 0.7× 89 0.7× 130 1.0× 88 983
Sung‐Hoon Park South Korea 21 559 1.3× 195 0.7× 74 0.5× 150 1.2× 218 1.7× 68 1.2k
Der-Yuan Chen Taiwan 20 449 1.1× 312 1.1× 47 0.3× 137 1.1× 227 1.8× 46 1.3k
Prabha Ranganathan United States 20 692 1.6× 214 0.8× 62 0.4× 271 2.1× 143 1.1× 53 1.3k
Nuntana Kasitanon Thailand 21 921 2.2× 431 1.5× 85 0.5× 69 0.5× 96 0.8× 72 1.3k
Wolfgang Salmhofer Austria 26 276 0.6× 347 1.2× 277 1.7× 72 0.6× 83 0.7× 54 1.5k
Anne Camez United States 19 436 1.0× 401 1.4× 163 1.0× 216 1.7× 69 0.5× 33 2.4k
Giacomo Cafaro Italy 19 306 0.7× 228 0.8× 74 0.5× 100 0.8× 161 1.3× 60 1.1k
N. K. Mehra India 20 253 0.6× 395 1.4× 94 0.6× 97 0.8× 254 2.0× 64 1.6k
W. Winn Chatham United States 13 281 0.7× 458 1.6× 69 0.4× 260 2.0× 213 1.7× 30 1.2k

Countries citing papers authored by Oliver Sander

Since Specialization
Citations

This map shows the geographic impact of Oliver Sander's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Oliver Sander with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Oliver Sander more than expected).

Fields of papers citing papers by Oliver Sander

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Oliver Sander. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Oliver Sander. The network helps show where Oliver Sander may publish in the future.

Co-authorship network of co-authors of Oliver Sander

This figure shows the co-authorship network connecting the top 25 collaborators of Oliver Sander. A scholar is included among the top collaborators of Oliver Sander based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Oliver Sander. Oliver Sander is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Keyßer, Gernot, et al.. (2024). Welches Potential hat ChatGPT 3.5 für eine qualifizierte Patienteninformation?. Zeitschrift für Rheumatologie. 84(3). 179–187. 1 indexed citations
2.
3.
Schmalzing, Marc, Oliver Sander, Reinhard Marks, et al.. (2024). Castleman’s disease in the rheumatological practice. Zeitschrift für Rheumatologie. 83(S3). 289–298.
4.
Frenken, Miriam, Benedikt Ostendorf, Ralph Brinks, et al.. (2023). Proof-of-Concept Double-Blind Placebo-Controlled Trial Measuring Cartilage Composition in Early Rheumatoid Arthritis under TNF-α-Inhibitor Therapy. Journal of Clinical Medicine. 12(6). 2306–2306.
5.
Keyßer, Gernot, Andreas Michalsen, Monika Reuß‐Borst, et al.. (2023). Empfehlungen der Kommission Komplementäre Heilverfahren und Ernährung zu ayurvedischer Medizin, Homöopathie, Ernährung und mediterraner Kost. Zeitschrift für Rheumatologie. 82(6). 517–531. 4 indexed citations
6.
Brinks, Ralph, Stefan Vordenbäumen, Hasan Acar, et al.. (2023). High Frequency of Osteophytes Detected by High-Resolution Ultrasound at the Finger Joints of Asymptomatic Factory Workers. Journal of Personalized Medicine. 13(9). 1343–1343.
7.
Ostendorf, Benedikt, Stefan Vordenbäumen, Ralph Brinks, et al.. (2022). Musculoskeletal ultrasound as a screening-tool for rheumatoid arthritis: results of the “Rheuma-Truck” screening and awareness initiative. Advances in Rheumatology. 62(1). 1–1. 3 indexed citations
8.
Hasseli, Rebecca, W. Hermann, Oliver Sander, & Konstantinos Triantafyllias. (2022). Kapillarmikroskopie – Grundlagen und klinische Anwendung. Zeitschrift für Rheumatologie. 81(4). 313–322. 5 indexed citations
9.
Mirna, Moritz, Fabian Hoffmann, Oliver Sander, et al.. (2020). Exposure to acute normobaric hypoxia results in adaptions of both the macro- and microcirculatory system. Scientific Reports. 10(1). 20938–20938. 11 indexed citations
10.
Mücke, Johanna, Ralph Brinks, Rebecca Fischer‐Betz, et al.. (2019). <p>Patient Satisfaction And Disease Control In Patients With Systemic Lupus Erythematosus Is Not Affected By Switching From Intravenous Belimumab To Subcutaneous Injections</p>. Patient Preference and Adherence. Volume 13. 1889–1894. 6 indexed citations
11.
Sander, Oliver, et al.. (2018). Rheumatologie im Spiegel der Medien und Werbung am Beispiel des Rheumazentrum Rhein-Ruhr. Zeitschrift für Rheumatologie. 77(4). 300–308. 1 indexed citations
12.
Richter, Jutta, Leticia Quintanilla-Martı́nez, K. Bienemann, et al.. (2012). An unusual presentation of a common infection. Infection. 41(2). 565–569. 14 indexed citations
13.
Sander, Oliver. (2010). Sicherheit der Biologika: Ergebnisse aus den Registern. Zeitschrift für Rheumatologie. 69(9). 788–794. 1 indexed citations
14.
Vordenbäumen, Stefan, Ellen Bleck, Jutta Richter, et al.. (2010). Altered serum levels of human neutrophil peptides (HNP) and human beta-defensin 2 (hBD2) in Wegener’s granulomatosis. Rheumatology International. 31(9). 1251–1254. 11 indexed citations
15.
Pomjanski, Natalia, H. Grote, Oliver Sander, et al.. (2008). Early cytological diagnosis of diffuse malignant mesothelioma of the peritoneum: A case report. Diagnostic Cytopathology. 36(2). 120–123. 9 indexed citations
16.
Iking‐Konert, Christof, Thomas Vogl, Birgit Prior, et al.. (2008). T lymphocytes in patients with primary vasculitis: expansion of CD8+ T cells with the propensity to activate polymorphonuclear neutrophils. Lara D. Veeken. 47(5). 609–616. 28 indexed citations
17.
Chehab, Gamal, Oliver Sander, Rebecca Fischer‐Betz, & Matthias Schneider. (2007). Anti-CD20-Therapie zur Remissionsinduktion und -erhaltung bei therapierefraktärem systemischen Lupus erythematodes. Zeitschrift für Rheumatologie. 66(4). 328–336. 8 indexed citations
18.
Sander, Oliver & Matthias Schneider. (2007). Arteriitis temporalis. DMW - Deutsche Medizinische Wochenschrift. 132(24). 1329–1338. 1 indexed citations
19.
Putte, Leo van de, Piet L. C. M. van Riel, Alfons A den Broeder, et al.. (1998). A SINGLE DOSE PLACEBO CONTROLLED PHASE I STUDY OF THE FULLY HUMAN ANTI-TNF ANTIBODY D2E7 IN PATIENTS WITH RHEUMATOID ARTHRITIS. Arthritis & Rheumatism. 41(9). 21 indexed citations
20.
Rau, R., Oliver Sander, & Predrag Musikic. (1998). Behandlung der chronischen Polyarthritis mit einem humanen rekombinanten Interleukin-1-Rezeptor-Antagonisten. Zeitschrift für Rheumatologie. 57(5). 312–319. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Josef Zadražil Breakdown of academic impact, for papers by Sung‐Hoon Park Breakdown of academic impact, for papers by Der-Yuan Chen Breakdown of academic impact, for papers by Prabha Ranganathan Breakdown of academic impact, for papers by Nuntana Kasitanon Breakdown of academic impact, for papers by Wolfgang Salmhofer Breakdown of academic impact, for papers by Anne Camez Breakdown of academic impact, for papers by Giacomo Cafaro Breakdown of academic impact, for papers by N. K. Mehra Breakdown of academic impact, for papers by W. Winn Chatham
Rankless by CCL
2026